PosterPerspectives: IBD Posters and Abstracts from Washington, DC
The following abstracts and posters were curated from all the posters presented at a recent gastroenterology congress held in Washington, DC. The central themes of these posters are drug safety, preventing disease recurrence, and switching among treatments. Specifically, the posters we selected highlight the incidence of serious infections and the efficacy associated with biologic agents and other immunomodulating therapies among patients with Crohn's disease and ulcerative colitis.
Gastroenterologists Dermont McGovern, MD, PhD, professor of medicine and director of translational medicine at the F. Widjaja Family Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, and David Rubin, MD, professor of medicine and section chief of gastroenterology, hepatology, and nutrition at the University of Chicago Medicine, Chicago, provide their perspectives on 10 recent studies regarding the management of Crohn's disease and ulcerative colitis.
National audience of gastroenterologists, primary care physicians, and other health care providers who manage patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis).
At the conclusion of this activity, participants should be better able to:
- Summarize the latest research developments in the management of Crohn's disease and ulcerative colitis
- Incorporate evidence-based research into clinical practice
You may participate by listening to any–or all–of the audio discussions. Click the 'Play' button to hear our faculty review the data and clinical implications of each poster/abstract. Two questions will appear at the end of each discussion. When ready to claim your CE/CME credit, complete the "Program Evaluation" and then click on the "Certificate" button to download your certificate
This activity is supported by an independent educational grant from AbbVie and Allergan, Inc.
- 2.50 AMA PRA Category 1 Credit(s)™
- 2.50 Attendance